4-溴甲基-7,8-二氟-2(1H)-喹啉酮 | 953070-72-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 中文名称: 4-溴甲基-7,8-二氟-2(1H)-喹啉酮
• 英文名称: 4-(bromomethyl)-7,8-difluoroquinolin-2(1H)-one
• 英文别名: 4-(bromomethyl)-7,8-difluoro-1H-quinolin-2-one
• CAS: 953070-72-9
• 化学式: C₁₀H₆BrF₂NO
• 分子量: 274.065
• InChiKey: YAJXWUVQJAQZDT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  3

上下游信息

• 下游产品

  中文名称	英文名称	CAS号	化学式	分子量
  ——	4-(bromomethyl)-2-chloro-7,8-difluoroquinoline	1125702-47-7	C10H5BrClF2N	292.51
  ——	4-((3-chlorophenylamino)methyl)-7,8-difluoroquinolin-2(1H)-one	953070-97-8	C16H11ClF2N2O	320.726
  ——	4-(((3-chlorophenyl)(phenyl)amino)methyl)-7,8-difluoroquinolin-2(1H)-one	1125861-68-8	C22H15ClF2N2O	396.824
  ——	7,8-difluoro-4-((2-isopropyl-1H-imidazol-1-yl)methyl)quinolin-2(1H)-one	1056935-20-6	C16H15F2N3O	303.311
  ——	4-((benzyl(pyrazin-2-yl)amino)methyl)-7,8-difluoroquinolin-2(1H)-one	1125863-38-8	C21H16F2N4O	378.381
  ——	7,8-difluoro-4-(((4-chlorobenzyl)(pyrazin-2-yl)amino)methyl)quinolin-2(1H)-one	1125864-32-5	C21H15ClF2N4O	412.826
  ——	4-(((3-chlorophenyl)(pyridin-4-yl)amino)methyl)-7,8-difluoroquinolin-2(1H)-one	1125862-18-1	C21H14ClF2N3O	397.811
  ——	7,8-difluoro-4-(((3-chlorobenzyl)(pyrazin-2-yl)amino)methyl)quinolin-2(1H)-one	1125864-30-3	C21H15ClF2N4O	412.826
  ——	7,8-difluoro-4-(((2-methylbenzyl)(pyrazin-2-yl)amino)methyl)quinolin-2(1H)-one	1125863-00-4	C22H18F2N4O	392.408
  ——	7,8-difluoro-4-(((2-fluorobenzyl)(pyrazin-2-yl)amino)methyl)quinolin-2(1H)-one	1125864-22-3	C21H15F3N4O	396.372

反应信息

• 作为反应物：
  描述：

  4-溴甲基-7,8-二氟-2(1H)-喹啉酮 在 三氯氧磷 作用下， 反应 3.0h， 以80%的产率得到4-(bromomethyl)-2-chloro-7,8-difluoroquinoline
  参考文献：
  名称：

  [EN] 4- [HETEROCYCLYL-METHYL] -8-FLUORO-QUINOLIN-2-ONES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS
  [FR] 4-[HÉTÉROCYCLYLMÉTHYL]-8-FLUORO-QUINOLIN-2-ONES UTILES COMME INHIBITEURS DE L'OXYDE NITRIQUE SYNTHASE

  摘要：

  已发现具有式（II，III）的新化合物和药物组合物能够抑制可诱导型NOS合酶，其中：R4、R5、R6和R7分别选自氢、较低烷基和卤素组成的群；而R8具有结构，其中X1、X2、X3、X4、X5、X6、R9、R13、R14和n如本文所述。

  公开号：

  WO2009029625A1
• 作为产物：
  描述：

  N-(2,3-二氟苯基)-3-氧代丁酰胺 在 硫酸 、 溴 、 溶剂黄146 作用下， 反应 2.0h， 生成 4-溴甲基-7,8-二氟-2(1H)-喹啉酮
  参考文献：
  名称：

  Heteroaromatic-aminomethyl quinolones: Potent and selective iNOS inhibitors

  摘要：

  The overproduction of nitric oxide during the biological response to inflammation by the nitric oxide synthase (NOS) enzymes have been implicated in the pathology of many diseases. By removal of the amide core from uHTS-derived quinolone 4, a new series highly potent heteroaromatic-aminomethyl quinolone iNOS inhibitors 8 were identified. SAR studies led to identification of piperazine 22 and pyrimidine 32, both of which reduced plasma nitrates following oral dosing in a mouse lipopolysaccharide challenge assay. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.11.073
• 作为试剂：
  描述：

  5－甲酸乙酯四氮唑 、 碘甲烷 、 乙酸乙酯 在 水 、 乙酸乙酯 、 Sodium sulfate-III 、 acetonitrile-water 、 4-溴甲基-7,8-二氟-2(1H)-喹啉酮 、 ( B ) 作用下， 以 Acetone dimethyl sulfoxide 为溶剂， 反应 24.0h， 生成 乙基2-甲基-2H-四唑-5-羧酸酯
  参考文献：
  名称：

  QUINOLONES USEFUL AS INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITORS

  摘要：

  本发明涉及式I的新型喹诺酮，其抑制可诱导型一氧化氮合酶，以及合成和使用该化合物的方法，包括通过给予该化合物治疗疾病的方法，用于抑制或调节一氧化氮合成和/或降低患者体内一氧化氮水平。

  公开号：

  US20080139558A1

文献信息

• [EN] DIARYLAMINE-SUBSTITUTED QUINOLONES USEFUL AS INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITORS<br/>[FR] QUINOLONES SUBSTITUÉES PAR DIARYLAMINE UTILES COMME INHIBITEURS DE L'OXYDE NITRIQUE SYNTHASE INDUCTIBLE.
  申请人：KALYPSYS INC

  公开号：WO2009029617A1

  公开（公告）日：2009-03-05

  Novel diarylamine-substituted quinolone compounds and pharmaceutical compositions, certain of which have been found to inhibit inducible NOS synthase have been discovered, together with methods of synthesizing and using the compounds including methods for the treatment of iNOS-mediated diseases in a patient by administering the compounds.

  已发现新的含有二芳胺基取代喹诺酮化合物和药物组合物，其中一些已被发现能抑制诱导型NOS合成酶，还包括合成和使用这些化合物的方法，包括通过给患者施用这些化合物治疗iNOS介导的疾病的方法。
• [EN] HETEROBICYCLIC-SUBSTITUTED QUINOLONES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS<br/>[FR] QUINOLONES À SUBSTITUTION PAR RESTE HÉTÉROBICYCLIQUE UTILES COMME INHIBITEURS DE L'OXYDE NITRIQUE SYNTHASE.
  申请人：KALYPSYS INC

  公开号：WO2009029592A1

  公开（公告）日：2009-03-05

  Novel Quinolone derivatives and pharmaceutical compositions, certain of which have been found to inhibit inducible NOS synthase have been discovered, together with methods of synthesizing and using the compounds including methods for the treatment of iNOS-mediated diseases in a patient by administering the compounds.

  新奎诺酮衍生物和药物组合物已被发现，其中一些已被发现能抑制诱导型NOS合酶，还有合成和使用这些化合物的方法，包括通过给患者施用这些化合物来治疗iNOS介导的疾病的方法。
• Discovery of Dual Inducible/Neuronal Nitric Oxide Synthase (iNOS/nNOS) Inhibitor Development Candidate 4-((2-Cyclobutyl-1<i>H</i>-imidazo[4,5-<i>b</i>]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1<i>H</i>)-one (KD7332) Part 2: Identification of a Novel, Potent, and Selective Series of Benzimidazole-Quinolinone iNOS/nNOS Dimerization Inhibitors That Are Orally Active in Pain Models
  作者：Joseph E. Payne、Céline Bonnefous、Kent T. Symons、Phan M. Nguyen、Marciano Sablad、Natasha Rozenkrants、Yan Zhang、Li Wang、Nahid Yazdani、Andrew K. Shiau、Stewart A. Noble、Peter Rix、Tadimeti S. Rao、Christian A. Hassig、Nicholas D. Smith

  DOI：10.1021/jm100828n

  日期：2010.11.11

  Three isoforms of nitric oxide synthase (NOS), dimeric enzymes that catalyze the formation of nitric oxide (NO) from arginine, have been identified. Inappropriate or excessive NO produced by iNOS and/or nNOS is associated with inflammatory and neuropathic pain. Previously, we described the identification of a series of amide-quinolinone iNOS dimerization inhibitors that although potent, suffered from high clearance and limited exposure in vivo. By conformationally restricting the amide of this progenitor series, we describe the identification of a novel series of benzimidazole-quinolinone dual iNOS/nNOS inhibitors with low clearance and sustained exposure in vivo. Compounds were triaged utilizing an LPS challenge assay coupled with mouse and rhesus pharmacokinetics and led to the identification of 4,7-imidazopyrazine 42 as the lead compound. 42 (KD7332) (J. Med. Chem. 2009, 52, 3047-3062) was confirmed as an iNOS dimerization inhibitor and was efficacious in the mouse formalin model of nociception and Chung model of neuropathic pain, without showing tolerance after repeat dosing. Further 42 did not affect motor coordination up to doses or 1000 mg/kg, demonstrating a wide therapeutic margin.
• Discovery of Inducible Nitric Oxide Synthase (iNOS) Inhibitor Development Candidate KD7332, Part 1: Identification of a Novel, Potent, and Selective Series of Quinolinone iNOS Dimerization Inhibitors that are Orally Active in Rodent Pain Models
  作者：Céline Bonnefous、Joseph E. Payne、Jeffrey Roppe、Hui Zhuang、Xiaohong Chen、Kent T. Symons、Phan M. Nguyen、Marciano Sablad、Natasha Rozenkrants、Yan Zhang、Li Wang、Daniel Severance、John P. Walsh、Nahid Yazdani、Andrew K. Shiau、Stewart A. Noble、Peter Rix、Tadimeti S. Rao、Christian A. Hassig、Nicholas D. Smith

  DOI：10.1021/jm900173b

  日期：2009.5.14

  There are three isoforms of dimeric nitric oxide synthases (NOS) that convert arginine to citrulline and nitric oxide. Inducible NOS is implicated in numerous inflammatory diseases and, mote recently, in neuropathic pain states. The majority of existing NOS inhibitors are either based on the structure of arginine or are substrate competitive. We describe the identification from an ultra high-throughput screen of a novel series of quinolinone small molecule, nonarginine iNOS dimerization inhibitors. SAR studies on the screening hit, coupled with an in vivo lipopolysaccharide (LPS) challenge assay measuring plasma nitrates and drug levels, rapidly led to the identification of compounds 12 and 42-potent inhibitors of the human and mouse iNOS enzyme that were highly selective over endothelial NOS (eNOS). Following oral dosing, compounds 12 and 42 gave a statistical reduction in pain behaviors in the mouse formalin model, while 12 also statistically reduced neuropathic pain behaviors in the chronic constriction injury (Bennett) model.
• [EN] QUINOLONES USEFUL AS INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITORS<br/>[FR] QUINOLONES UTILES EN TANT QU'INHIBITEURS DE L'OXYDE NITRIQUE SYNTHASE INDUCTIBLE
  申请人：KALYPSYS INC

  公开号：WO2007117778A9

  公开（公告）日：2009-05-22